Low Intensity Warfarin Anticoagulation is Safe and Effective as a Long-Term Venous Thromboembolism Prevention Strategy

By Goldhaber Samuel  

Journal of Thrombosis and Thrombolysis, Vol. 21, Iss. 1, 2006-02 ,pp. : 51-52

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism

By Kearon C.   Ginsberg J.S.   Kovacs M.J.   for the Extended Low-Intensity Anticoagulation for Thrombo-Embolism Investigators  

ACC Current Journal Review, Vol. 12, Iss. 6, 2003-11 ,pp. : 16-16

Elsevier

Access to resources Recommend Favorite

The Standard is Still the Standard or Why an INR of 2–3 is Still the Optimal Intensity for Secondary Prevention of Venous Thromboembolism

By Kovacs Michael  

Journal of Thrombosis and Thrombolysis, Vol. 21, Iss. 1, 2006-02 ,pp. : 53-56

Springer Publishing Company

Access to resources Recommend Favorite

Long-term Treatment of Venous Thromboembolism

By  

Current Vascular Pharmacology, Vol. 12, Iss. 3, 2014-05 ,pp. : 384-392

Bentham Science Publishers

Access to resources Recommend Favorite

Low-molecular-weight heparin vs. a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

By Lee A.Y.Y.   Levine M.N.   Baker R.I.   for the Randomized Comparison of Low-Molecular-Weight Heparin vs. Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer CLOT Investigators  

ACC Current Journal Review, Vol. 12, Iss. 5, 2003-09 ,pp. : 19-20

Elsevier

Access to resources Recommend Favorite